China Health Industries Holdings Inc
OTC:CHHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
China Health Industries Holdings Inc
OTC:CHHE
|
CN |
Intrinsic Value
The intrinsic value of China Health Industries Holdings Inc (CHHE) under the Base Case is 0.0003 USD per share.
Compared with the current market price of 0.0001 USD, the stock appears
Undervalued by 62% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What China Health Industries Does
China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia).
- Headquarters
- China CN
- Employees
- 32
- IPO date
- Dec 1, 2004
Revenue & Expenses Breakdown
China Health Industries Holdings Inc
Earnings Waterfall
China Health Industries Holdings Inc
The intrinsic value for China Health Industries Holdings Inc (CHHE) under the Base Case is 0.0003 USD.
Compared with the current market price of 0.0001 USD, the stock appears Undervalued by 62% .